Cargando…

Clinical Association of Chemokine (C-X-C motif) Ligand 1 (CXCL1) with Interstitial Pneumonia with Autoimmune Features (IPAF)

The term “interstitial pneumonia with autoimmune features” (IPAF) has been recently proposed. We here investigate the clinical characteristics of IPAF and evaluate the clinical implications of CXCL1-CXCR2 axis in IPAF. An increased plasma level of CXCL1 was exhibited in IPAF compared to idiopathic i...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Minrui, Jiang, Zhixing, Huang, Qiong, Liu, Lei, Xue, Yu, Zhu, Xiaoxia, Yu, Yiyun, Wan, Weiguo, Yang, Haihua, Zou, Hejian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154180/
https://www.ncbi.nlm.nih.gov/pubmed/27958346
http://dx.doi.org/10.1038/srep38949
_version_ 1782474834809192448
author Liang, Minrui
Jiang, Zhixing
Huang, Qiong
Liu, Lei
Xue, Yu
Zhu, Xiaoxia
Yu, Yiyun
Wan, Weiguo
Yang, Haihua
Zou, Hejian
author_facet Liang, Minrui
Jiang, Zhixing
Huang, Qiong
Liu, Lei
Xue, Yu
Zhu, Xiaoxia
Yu, Yiyun
Wan, Weiguo
Yang, Haihua
Zou, Hejian
author_sort Liang, Minrui
collection PubMed
description The term “interstitial pneumonia with autoimmune features” (IPAF) has been recently proposed. We here investigate the clinical characteristics of IPAF and evaluate the clinical implications of CXCL1-CXCR2 axis in IPAF. An increased plasma level of CXCL1 was exhibited in IPAF compared to idiopathic interstitial pneumonia (IIP), chronic obstructive pulmonary disease (COPD), and healthy controls. Additionally, plasma CXCL1 levels were clinically associated with diffusing capacity of the lungs for carbon monoxide (DLCO), erythrocyte sedimentation rate (ESR), and involved parenchyma extension in IPAF. Furthermore, circulating CXCL1 levels were highest in IPAF patients with acute exacerbations. CXCR2, the chemokine receptor for CXCL1, was readily observed in inflammatory aggregates and endothelial cells in IPAF lungs, but was lower in IIP lungs and healthy lungs. Interestingly, increased CXCL1 concentrations in BALF paralleled neutrophil counts in IPAF. Overall, the plasma concentrations of CXCL1 indicated the disease activity and prognosis in IPAF. Thus, the CXCL1/CXCR2 axis appears to be involved in the progression of IPAF.
format Online
Article
Text
id pubmed-5154180
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-51541802016-12-28 Clinical Association of Chemokine (C-X-C motif) Ligand 1 (CXCL1) with Interstitial Pneumonia with Autoimmune Features (IPAF) Liang, Minrui Jiang, Zhixing Huang, Qiong Liu, Lei Xue, Yu Zhu, Xiaoxia Yu, Yiyun Wan, Weiguo Yang, Haihua Zou, Hejian Sci Rep Article The term “interstitial pneumonia with autoimmune features” (IPAF) has been recently proposed. We here investigate the clinical characteristics of IPAF and evaluate the clinical implications of CXCL1-CXCR2 axis in IPAF. An increased plasma level of CXCL1 was exhibited in IPAF compared to idiopathic interstitial pneumonia (IIP), chronic obstructive pulmonary disease (COPD), and healthy controls. Additionally, plasma CXCL1 levels were clinically associated with diffusing capacity of the lungs for carbon monoxide (DLCO), erythrocyte sedimentation rate (ESR), and involved parenchyma extension in IPAF. Furthermore, circulating CXCL1 levels were highest in IPAF patients with acute exacerbations. CXCR2, the chemokine receptor for CXCL1, was readily observed in inflammatory aggregates and endothelial cells in IPAF lungs, but was lower in IIP lungs and healthy lungs. Interestingly, increased CXCL1 concentrations in BALF paralleled neutrophil counts in IPAF. Overall, the plasma concentrations of CXCL1 indicated the disease activity and prognosis in IPAF. Thus, the CXCL1/CXCR2 axis appears to be involved in the progression of IPAF. Nature Publishing Group 2016-12-13 /pmc/articles/PMC5154180/ /pubmed/27958346 http://dx.doi.org/10.1038/srep38949 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Liang, Minrui
Jiang, Zhixing
Huang, Qiong
Liu, Lei
Xue, Yu
Zhu, Xiaoxia
Yu, Yiyun
Wan, Weiguo
Yang, Haihua
Zou, Hejian
Clinical Association of Chemokine (C-X-C motif) Ligand 1 (CXCL1) with Interstitial Pneumonia with Autoimmune Features (IPAF)
title Clinical Association of Chemokine (C-X-C motif) Ligand 1 (CXCL1) with Interstitial Pneumonia with Autoimmune Features (IPAF)
title_full Clinical Association of Chemokine (C-X-C motif) Ligand 1 (CXCL1) with Interstitial Pneumonia with Autoimmune Features (IPAF)
title_fullStr Clinical Association of Chemokine (C-X-C motif) Ligand 1 (CXCL1) with Interstitial Pneumonia with Autoimmune Features (IPAF)
title_full_unstemmed Clinical Association of Chemokine (C-X-C motif) Ligand 1 (CXCL1) with Interstitial Pneumonia with Autoimmune Features (IPAF)
title_short Clinical Association of Chemokine (C-X-C motif) Ligand 1 (CXCL1) with Interstitial Pneumonia with Autoimmune Features (IPAF)
title_sort clinical association of chemokine (c-x-c motif) ligand 1 (cxcl1) with interstitial pneumonia with autoimmune features (ipaf)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154180/
https://www.ncbi.nlm.nih.gov/pubmed/27958346
http://dx.doi.org/10.1038/srep38949
work_keys_str_mv AT liangminrui clinicalassociationofchemokinecxcmotifligand1cxcl1withinterstitialpneumoniawithautoimmunefeaturesipaf
AT jiangzhixing clinicalassociationofchemokinecxcmotifligand1cxcl1withinterstitialpneumoniawithautoimmunefeaturesipaf
AT huangqiong clinicalassociationofchemokinecxcmotifligand1cxcl1withinterstitialpneumoniawithautoimmunefeaturesipaf
AT liulei clinicalassociationofchemokinecxcmotifligand1cxcl1withinterstitialpneumoniawithautoimmunefeaturesipaf
AT xueyu clinicalassociationofchemokinecxcmotifligand1cxcl1withinterstitialpneumoniawithautoimmunefeaturesipaf
AT zhuxiaoxia clinicalassociationofchemokinecxcmotifligand1cxcl1withinterstitialpneumoniawithautoimmunefeaturesipaf
AT yuyiyun clinicalassociationofchemokinecxcmotifligand1cxcl1withinterstitialpneumoniawithautoimmunefeaturesipaf
AT wanweiguo clinicalassociationofchemokinecxcmotifligand1cxcl1withinterstitialpneumoniawithautoimmunefeaturesipaf
AT yanghaihua clinicalassociationofchemokinecxcmotifligand1cxcl1withinterstitialpneumoniawithautoimmunefeaturesipaf
AT zouhejian clinicalassociationofchemokinecxcmotifligand1cxcl1withinterstitialpneumoniawithautoimmunefeaturesipaf